California brand Greenline opens its first store, completing a seed-to-sale model. Here’s what a vertical move like this means for delivery, investors, and DMV entrepreneurs.

An Australian firm filed a THC-free CBD pain tablet with TGA approval in mind, but its own trial reportedly didn’t beat placebo—raising product, market, and investor questions.

Durango Organics’ Jonny Radding shares survival themes from Colorado’s boom-bust. We translate them into delivery models, DMV opportunities, and investor risk checks.

A new DEA registration pathway pulls state-licensed medical cannabis manufacturers, distributors, and labs into the federal Schedule III framework—potentially easing 280E tax pain.

High Times reports Italy’s fentanyl scarcity despite entrenched opioid use and powerful crime networks. We unpack what that evidence means for drug markets—and the cannabis delivery business.

Alleged retaliatory firings at a Missouri dispensary highlight workforce risks that can ripple into dispensary delivery, cannabis delivery apps, and investor sentiment across markets.

Rescheduling momentum is real, but tax experts say cannabis businesses may remain under 280E for the entire 2025 tax year. Here’s what that means for DMV operators and delivery services.

Greenlight dispensary workers in Missouri allege retaliatory firings after an organizing meeting as another store votes to unionize. Here’s what operators, investors, and delivery entrepreneurs should watch.

Developers are exploring distressed cultivation facilities for their power, cooling and security. Here’s how a pivot to AI infrastructure could reshape the DMV market.

MJBizDaily reports a $4.5M buy of PharmaCann’s New York medical cannabis permit by Grown Rogue, aiming at a shortage of indoor flower canopy. Here’s why it matters for cultivation, delivery compliance, and DMV consumers.

A $2,500 settlement over about 200 plants shows how fast compliance gaps become costly. Here’s what DMV operators, delivery builders, and investors should learn now.

Connecticut’s volume is up but dollars aren’t keeping pace. Here’s what price compression means for cannabis delivery models, investors, and DMV operators planning their next move.

A federal ban on intoxicating hemp products could shutter most U.S. hemp businesses. Here’s how the disruption ripples through delivery models, apps, and DMV operators—and what to do next.

Shoppers now expect deals to be the default. We unpack how a 26% discount norm reshapes delivery economics, pricing strategy, and DMV opportunities.

Shatter’s glassy chemistry explains its appeal—and raises big questions for delivery logistics, investment strategy, and what’s next for DC, Maryland and Virginia operators.

MJBizDaily reports 87 New York retailers are on a cash‑on‑delivery list, owing about $45,000 each as 2026 sales lag projections. Here’s what it signals for delivery, compliance, and the DMV.

Christina Lake Cannabis is reviewing dueling offers—one to buy the company, one to buy its assets. Here’s what the $15M vs $18M spread could signal for delivery models and investors.

Operational change is the earliest safety-and-cost signal in cannabis logistics. Here’s how delivery operators and investors can turn risk awareness into business edge.

Aurora told shareholders not to tender to Curaleaf’s hostile bid and signaled it’s weighing alternatives, sharpening focus on valuation, upside sharing, and voting control.